This blog documents Caroline's cancer journey. November 2017: Diagnosed with Stage IV, High-Risk Neuroblastoma...April 2019: Completed treatment protocol and declared to have no evidence of disease; enrolled in DFMO Clinical Trial...April 2021: Completed DFMO clinical trial...April 2022: Neuroblastoma Relapsed...June 2023: Completed treatment protocol and declared to have no evidence of disease; enrolled in “compassionate use” high-dose DFMO clinical trial.
Monday, March 13, 2023
Cycle 13 on 3/13
Caroline made her blood count requirements today for inpatient admission of Cycle 13 (of 17) for chemotherapy/immunotherapy treatment for her relapsed Neuroblastoma. She is in good spirits...especially with the fun room decorations ☘️ for St. Patrick’s Day, thanks to the help of Michelle P.!
Please pray for a relatively uneventful week of side effects; we hope to be discharged on Saturday.